tiprankstipranks
PureTech Health (NASDAQ:PRTC) Considering Merger with Nektar
Market News

PureTech Health (NASDAQ:PRTC) Considering Merger with Nektar

Shares of PureTech Health (NASDAQ: PRTC) were trending lower in pre-market trading on Friday even as the biotherapeutics company confirmed that it had “exchanged indicative, non-binding proposals with Nektar Therapeutics regarding a possible combination.”

The company was in ongoing discussions with Nektar (NASDAQ: NKTR) and Nektar will be required by no later than 5.00 p.m. on November 3 to either make a firm offer or announce that it does not intend to make an offer.

Is PureTech a Buy, Hold or Sell?

Only two analysts have covered the stock in the past three months and both have a Buy rating on the stock.

The average price target for PRTC stock is $57 with an upside potential of 83.8% at current levels.

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles